4 years ago

Microbiological and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality

Biofilm formation (BF) by fungal isolates may dramatically complicate infection. We determined the ability of C. parapsilosis isolates from single fungaemia episodes to form biofilms and we analysed biofilm subgroups for antifungal susceptibility and pathogenic potential. We then correlated BF with clinical characteristics and outcomes of the episodes. Methods BF was measured using the crystal-violet biomass assay, antifungal susceptibility of preformed biofilms was assessed, and virulence was studied using the Galleria mellonella model. A retrospective analysis of patients’ clinical records was performed. Results Of 190 patient-unique isolates, 84, 38 and 68 were identified as having high BF, moderate BF or low BF, respectively. Among 30 randomly selected isolates, 9 (8 HBF and 1 MBF), 6 (all HBF) and 1 (HBF) isolates had elevated sessile MICs (SMICs) to fluconazole, anidulafungin or amphotericin B, respectively; all HBF and MBF isolates had elevated voriconazole SMICs. G. mellonella killing rates of HBF isolates were significantly greater than MBF (or LBF) isolates (50% vs. 20%, 2 days from infection). By comparing HBF/MBF (106 patients) and LBF (84 patients) groups, we found that HBF/MBF patients had more central venous catheter (CVC)-related fungaemias (62/106 [58.5%] vs. 29/84 [34.5%], p 0.001) and were more likely to die at 30 days from fungaemia onset (61/106 [57.5%] vs. 28/84 [33.3%], p 0.01). In the HBF/MBF group, azole antifungal therapy and CVC removal were significantly associated with a higher and lower 30-day mortality rate, respectively. Conclusions We conclude that C. parapsilosis BF influences the clinical outcome in patients with fungaemia.

Publisher URL: www.sciencedirect.com/science

DOI: S1198743X17306353

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.